Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Management team
View:
Post by jimmynuchereno on Sep 06, 2022 4:32pm

Management team

I started working closely with Rodger back in 2006. I bought two lasers and was and was so excited about this technology I actually worked with Roger as close as possible. I attended conferences with him where we sold systems as a team. Roger is an excellent technician and engineer but does not have the management skills and even common sense. He had the greatest product Superior to everyone else out there but the salesman were poorly trained and not allowed to do demonstrations!! I asked him to let me handle the sales and of the business with my background but not being a Canadian I think that was a problem especially if he was getting any kind of federal funding. Regarding as to the information coming out regarding the cancer research you have to assume they are telling it like it is. Roger got into trouble once already at Great expense and I can't believe he would expose himself to some additional fraudulent or exaggerated information. I have not talked to Roger in several years due to him really focusing on the cancer end of the business and pulling out of the United States. The market really is pretty well saturated as far as chiropractors.
Comment by DJDawg on Sep 07, 2022 9:28am
Thanks for posting on something that is not known to many of us - the mystery Roger variable. Sent you a DM. Dawg
Comment by ab1111 on Sep 07, 2022 12:24pm
nice definition of roger. just sent you a message, hope to hear something. ab1112
Comment by Lesalpes29 on Sep 07, 2022 12:34pm
Youppi a new member to push that management is bad and this stock is bad.
Comment by Yoly900 on Sep 07, 2022 12:49pm
This post has been removed in accordance with Community Policy
Comment by Yoly900 on Sep 07, 2022 12:54pm
This post has been removed in accordance with Community Policy
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250